CalPERS Plans To Withhold Votes for Eli Lilly Executives
On Thursday, CalPERS said it plans to withhold votes for three Eli Lilly directors up for re-election next month, citing the drug maker's lagging stock price and poor corporate governance. In a written statement, Eli Lilly said CalPERS' assessment of the three directors was unsupportive of and unresponsive to shareholders.
- "CalPERS To Withhold Votes for 3 Eli Lilly Directors" (Loftus, Dow Jones, 3/27).